Furthermore, adding other biomarkers like residual cholesterol or D-dimer to the Lp(a) and Hs-CRP combination has shown that the highest levels of these markers correlate with the greatest risk of adverse outcomes in CHD patients (42, 43). This evidence concerns the gene CRP and coronary artery disorder.